
DOC Stock Forecast & Price Target
DOC Analyst Ratings
Bulls say
Healthpeak Properties maintains a robust outlook, driven by its diversified healthcare portfolio, which comprises approximately 700 properties that include medical office and life science assets, alongside senior housing and skilled nursing facilities. The company is actively enhancing its medical office building (MOB) portfolio through new development projects valued at $148 million, demonstrating strong pre-leasing rates of around 80% and projected stabilized yields in the mid-7% range. This strategic expansion, along with the positive market dynamics surrounding healthcare real estate, underscores a favorable long-term growth trajectory for Healthpeak Properties.
Bears say
Healthpeak Properties's stock outlook is negatively impacted by increased credit risk associated with lab tenants, leading to a revision of the 2026 estimated price-to-adjusted funds from operations (P/AFFOPS) multiple from 13.0x to 12.0x. Additionally, weak leasing activity reported in Q2 has prompted a downgrade in the growth forecast for funds from operations and adjusted funds from operations (FFOPS/AFFOPS) to a compound annual growth rate (CAGR) of +1%/-1% for 2026-2027, down from +2%/+1% previously. The potential headwinds to lab occupancy anticipated in the second half of 2025, driven by slow capital raising efforts, further exacerbates the challenges facing Healthpeak’s financial performance.
This aggregate rating is based on analysts' research of Healthpeak Properties Inc and is not a guaranteed prediction by Public.com or investment advice.
DOC Analyst Forecast & Price Prediction
Start investing in DOC
Order type
Buy in
Order amount
Est. shares
0 shares